A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled…

Overview of attention for article published in Frontiers in immunology, February 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 7 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 38,111 followers.

Exciting clinical trial investigating metformin as add-on treatment for non-active progressive multiple sclerosis to delay disease progression. #MultipleSclerosis #Metformin https://t.co/zguTBmljq0

30 Apr 2024

Reply Repost Favourite

A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial #MECFS #LongCovid https://t.co/JTqXhdK2wV

26 Feb 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegenerati…

21 Feb 2024

Reply Repost Favourite

New Research: A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial: Introduction:… https://t.co/HoZ3e

21 Feb 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.